Eli Lilly (LLY) PT Raised to $1,327 at Morgan Stanley

April 10, 2026 8:15 AM

Morgan Stanley analyst Terence Flynn raised the price target on Eli Lilly (NYSE: LLY) to $1,327.00 (from $1,313.00) while maintaining a Overweight rating.

No results found